Drug-coated balloon developer Urotronic raises $6m

This article was originally published here

Urotronic has raised $6.1 million in an equity offering involving 21 investors, according to a document filed with the SEC this week.

The Minnesota-based company has not publicly stated how it plans to spend its newly-acquired funds. Urotronic is developing a drug-coated balloon catheter designed to treat urethral strictures in men.

Get the full story at our sister site, Drug Delivery Business News.

The post Drug-coated balloon developer Urotronic raises $6m appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply